EU-Japan Biotech & Pharma Partnering Conference 2026

16 Sept – 5 Oct 2026 | Osaka, Japan

Abolis Biotechnologies

Company (SME/startup) / 中小企業・スタートアップ

www.abolis.fr/Evry, France
53 profile visits

About

Abolis Biotechnologies is a French biotechnology company specialising in microbial systems and industrial-grade biotech applications for the food, cosmetics, healthcare and chemical industries. The company helps innovators, manufacturers and R&D teams understand complex microbial systems and address critical industrial challenges through ingredient and biotics development, process optimisation and product innovation. Combining expertise in strain engineering, microbial metabolism, fermentation and bioprocess development with proprietary technologies and an integrated industrial approach, Abolis supports projects from early discovery through to scale-up readiness and industrial application.

Social media

Areas of activity

Business Domain / 分野

Pharmaceuticals / 医薬品Information technology / ITHealthcare / ヘルスケアFoods / 食品Consultant / コンサルタント

Modalities / モダリティ

Small-molecule drug / 低分子医薬

Business Type / 業種

CRO (Preclinical) / 開発業務受託(非臨床)

Technologies / 技術

Pharmaceutical ingredients / 医薬品原料

Additional information

Researched company/organisation type / マッチングご希望企業・機関のタイプ

Companies and Academia etc. (Joint research and development purpose) / 企業やアカデミア等(共同での研究、開発を目的)Companies and Entities (Providing your services or technology to your clients) / 技術・サービス(研究、開発、製造等の提供を目的)CROs, CMOs, CDMOs, etc. (Partnerships)/CRO、CMO、CDMO等(インライセンス、共同研究などを目的)

Researched disease area / マッチングご希望の疾患領域

Oncology / がんNeurology & Psychiatryy / 中枢神経、精神疾患Immunology / 免疫・炎症Metabolic diseases / 代謝

Researched Modality / マッチングご希望のモダリティ

Small-molecule drug/低分子医薬Peptide, Protein / ペプチド、タンパクOligonucleotide drug / 核酸医薬Others / その他

Researched Technologies / マッチングご希望の技術

Cell cultivation system and 3D-bioprinter/ 細胞培養装置、3DプリンターCell separation/ 細胞分離

Marketplace (1)

  • Expertise

    Strain Engineering

    Abolis is a specialized biotech partner offering end-to-end solutions for bio-based product innovation.